Streltima 45 mg, Injektionslösung

7680705240012 CH-70524 Injektionslösung

Associated product:

STRELTIMA sol inj 45 mg/0.5ml flac

No image available

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
ustekinumabum
45.0 MG Substance Wirkstoff (Principe actif)
saccharum
- Substance HNIDK
histidinum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
70524
Drug name
Streltima, Injektionslösung
Galenic form
LSPA
ATC Code
L04AC05
Authorization status
Z
Authorization category
Category C
Dispensing category
B
First authorization
30/09/2025
Authorization expiration date
30/09/2026
IT Number
07.15.0.
Domain
Human medicine
Field of application
Plaque-Psoriasis ab 6 Jahren, Psoriasis-Arthritis bei Erwachsenen, Morbus Crohn bei Erwachsenen, Ulcerative colitis bei Erwachsenen

Package details

Description (FR)
STRELTIMA sol inj 45 mg/0.5ml flac
Description (DE)
STRELTIMA Inj Lös 45 mg/0.5ml Durchstf
Market launch
24/12/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data